21 reports

Q. ##.

  • OTC
  • Europe
  • Arla Foods
  • Cargill Inc.
  • Ingredion Incorporated

MARKET ##.

  • Fitness
  • OTC
  • Vitamin
  • Europe
  • Demand

MARKET ##.

  • Herbal Supplement
  • OTC
  • Europe
  • World
  • Company Sales

OTC Distribution in Europe - 2016 Edition OTC Distribution in Europe - The 2016 Edition - The New Global Agenda Chapter ##: Distribution of OTC Medicines in Europe – Introduction, Market Definitions and Summary of Key Issues Forward to the 2016 Study of the Distribution of

  • OTC
  • Pharmaceutical
  • Pharmacy
  • Europe

OVER THE COUNTER (OTC) ##.

  • Antifungal
  • OTC
  • Europe

For this report, CAGR for historic time period is Calculated from 2012-2017, as CAGR = ((2017 Value / 2012 Value) ^ (## / (2017-2012))) - ## CAGR for forecast time period is Calculated from 2017-2022, as CAGR = ((2022 Value / 2017 Value) ^ (## / (2022-2017

  • Hair Growth
  • OTC
  • Pharmaceutical
  • Europe
  • Spain

For this report, CAGR for historic time period is Calculated from 2012-2017, as CAGR = ((2017 Value / 2012 Value) ^ (## / (2017-2012))) - ## CAGR for forecast time period is Calculated from 2017-2022, as CAGR = ((2022 Value / 2017 Value) ^ (## / (2022-2017

  • OTC
  • Europe
  • Market Size
  • Amway Corporation
  • Lornamead, Inc

OTC OBESITY ##. ##. ##.

  • OTC
  • Weight Loss
  • Europe

K-Y, which has been sold OTC (over the counter) since 1980, has a strong brand presence worldwide and is available in over ## countries.

  • OTC
  • Sexual Wellness
  • Europe
  • Market Size
  • Reckitt Benckiser Group plc

MARKET ##.

  • Dietary Supplement
  • Functional Food
  • Nutraceutical
  • OTC
  • Europe

OTC Tablet ##. ##. ##.

  • Antifungal
  • OTC
  • Therapy
  • Europe
  • Market Size

Companies mentioned ##.

  • Gastrointestinal Drug
  • OTC
  • Europe
  • THREAT OF SUBSTITUTES
  • FACTORS INFLUENCING THE THREAT OF SUBSTITUTES IN THE OTC PHARMACEUTICALS MARKET IN EUROPE, 2015

OTC products are marketed under Tylenol, Sudafed, Benadryl, Zyrtec, Motrin IB ibuprofen and Pepcid.

  • OTC
  • Europe
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson

MARKET ##.

  • Contraceptive
  • OTC
  • Europe
  • World
  • Trade
  • OMEGA PHARMA COMPLETES ACQUISITION OF IDENTIFIED NON-CORE OTC BRANDS IN EUROPE FROM GSK FOR US$614 MILLION
  • OMEGA PHARMA ACQUIRES RIGHTS TO OPTALIDON FROM NOVARTIS CONSUMER HEALTH

Deal historyCompleted: On July ##, 2012, Omega Pharma completed the acquisition of identified non-core OTC brands in Europe from GlaxoSmithKline for a purchase consideration of €##m (US$##m) in cash.

  • OTC
  • Europe
  • Corporate Finance
  • M&A
  • Omega

COMPANY PROFILES Total Companies Profiled: ## (including Divisions/ Subsidiaries - ##) The United States (##) Canada (##) Japan (##) Europe (##) - France (##) - Germany (##) - The United Kingdom (##) - Italy (##) - Spain (##) - Rest of Europe (##) Asia-Pacific (Excluding Japan

  • Ophthalmic Solution
  • OTC
  • APAC
  • Europe
  • Company Sales

The European / Russian Phase III Estelle® study has enrolled ##, ## subjects aged ## - ## years of whom ##, ## subjects are aged ## - ## years.

  • Contraceptive
  • OTC
  • Pharmaceutical
  • Europe
  • Mithra

The brands of the products acquired are OTC (over-the-counter) pharmaceuticals and dietary supplements.

  • Healthcare
  • OTC
  • Pharmaceutical
  • Therapy
  • Europe

The magnitude of the impact has been categorized as described below: Low Moderate High - Negligible or no impact on the market landscape - Medium-level impact on the market - Very high impact, with radical influence on the growth of the market ## ## ## ## ## Low High ## ## ## ## ## Low High

  • OTC
  • Europe
  • B. Braun Medical
  • Coloplast Group
  • Kimberly-Clark Corporation

The brands of the products acquired are OTC (over-the-counter) pharmaceuticals and dietary supplements.

  • Healthcare
  • OTC
  • Pharmaceutical
  • Therapy
  • Europe

MARKET ##.

  • Contraceptive
  • OTC
  • APAC
  • Europe
  • Company Sales